About Cyclacel Pharmaceuticals

Sitemap

• About
  • Company overview
  • Research and Development Pipeline
  • People
    • Board of Directors
    • Management Team
    • Scientific Advisory Board
  • Alliances and Collaborations
• Research & Development
  • Programs
    • Clinical Oncology Programs
      • Sapacitabine (CYC682)
      • Seliciclib (CYC202)
      • CYC116 Aurora Kinase & VEGFR2 Inhibitor
    • Other Programs
  • Science and Technology
    • Cell Cycle in Cancer
    • Drug Discovery & Development Approach
  • Clinical Trials
  • Publications
• Investors & Media
  • Corporate Governance
    • Board of Directors
    • Committee Composition
    • Management Team
  • Common Stock Information
  • News
  • SEC Filings
  • Analysts
  • Corporate Presentations & Events
  • Corporate Factsheet
  • Annual Reports
  • Request Investor Pack
• Careers
• Contact
• Alerting Service